$85,000
We know that UBE3A action inside brain cells is extremely complicated but the research of Dr. Greenberg and his lab has greatly helped to dissect and better understand this complexity. Using mouse models and using powerful genetic technologies to study individual neuron cells, their lab identified new protein targets that regulate synaptic development and activity. Importantly, these new proteins are related to other proteins for which druggable targets have been established and this area of research is creating new ideas about possible new pharmaceutical or other novel types of treatment approaches.
The mission of Angelman Syndrome Foundation is to advance the awareness and treatment of Angelman syndrome through education and information, research and support for individuals with Angelman syndrome, their families and other concerned parties. We exist to give all of them a reason to smile, with the ultimate goal of finding a cure.